Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks.
about
A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsProactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings: Opinion of the COST Action Network AMiCIAccurate and interpretable nanoSAR models from genetic programming-based decision tree construction approaches.Nanomedicinal products: a survey on specific toxicity and side effects.Nanomaterials: certain aspects of application, risk assessment and risk communication.
P2860
Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Difficulties in establishing r ...... ce between benefits and risks.
@en
type
label
Difficulties in establishing r ...... ce between benefits and risks.
@en
prefLabel
Difficulties in establishing r ...... ce between benefits and risks.
@en
P2093
P2860
P356
P1476
Difficulties in establishing r ...... nce between benefits and risks
@en
P2093
Ismael Manuel Urrutia-Ortega
Luis Guillermo Garduño-Balderas
Yolanda Irasema Chirino
P2860
P304
P356
10.1002/JAT.3180
P407
P577
2015-06-05T00:00:00Z